Anthera Pharmaceuticals Inc
Biotechnology · Hayward, CA
Data ndekọ gọọmentị
0ndị na-eso
2004tọrọ ntọala
Maka Anthera Pharmaceuticals Inc
Anthera Pharmaceuticals, Inc. is an American biopharmaceutical company focused on developing and commercializing products to treat serious conditions associated with cystic fibrosis, inflammation and autoimmune diseases. Liprotamase (Sollpura), Anthera's leading drug candidate which is being developed for exocrine pancreatic insufficiency (EPI) is currently in Phase 3 clinical trials, and A-623 (Blisibimod) for the treatment of IgA nephropathy is currently in Phase 2 clinical trial.
Source: Wikipedia
NgalabaBiotechnology
Isi ụlọ ọrụHayward, CA
Tọrọ ntọala2004
Ụdị iwuC Corporation
ỌnọdụNa-arụ ọrụ
Patent1 patent
PHARMACEUTICAL COMPOSITION CONTAINING PHOSPHOLIPASE INHIBITOR SODIUM [[3-(2-AMINO-1,2-DIOXOETHYL)-2-ETHYL-1-(PHENYLMETHYL)-1H-INDOL-4-YL]OX…JP2011021042A · 2011
Nyocha
Enweghị nyocha ugbu a. Ị rụrụ ọrụ na Anthera Pharmaceuticals Inc? Bụrụ onye mbụ kekọrịta ahụmahụ gị.
Ọnụọgụ isi
Banye iji hụ ọnụ ọgụgụ ndị isi
Ego mbata, uru net na ọnụ ọgụgụ ndị ọrụ nke Anthera Pharmaceuticals Inc ka afọ na-aga, tinyere isi mmalite ha.
Banye Mepụta akaụntụ site n'ozi-e gịỌ bụ n'efu
Site n'ịga n'ihu, ị na-ekweta Nkwekọrịta onye ojiji, Amụma nzuzo na Amụma kuki nke Heelky.
Ozi iwu
| Aha iwu | Anthera Pharmaceuticals Inc |
|---|---|
| Ụdị iwu | C Corporation |
| SEC CIK | 1316175Lee na SEC EDGAR ↗ |
| Adreesị edebanyere aha | Hayward, CA |
| Ọnọdụ | Na-arụ ọrụ |
Isi mmalite: SEC EDGAR · emelitere 14 Nọvemba 2026
Kọntaktị & njikọ
Ebe
Hayward, CA
Nke a ọ bụ ụlọ ọrụ gị?
Kwuo ibe a n'efu iji tinye logo gị, ngwaahịa, foto na ọrụ, na iza nyocha.
Kwuo ibe aSonye na Heelky iji jikọọ, were ndị ọrụ ma too
Mepụta akaụntụ efu iji zipụ ndị mmadụ ozi, tinye arịrịọ ọrụ ma bipụta mishọn.
Sonye ugbu a — ọ bụ n'efu